<DOC>
	<DOCNO>NCT00241228</DOCNO>
	<brief_summary>Sepsis septic shock still important cause mortality intensive care medicine . Renal replacement therapy standard volume haemofiltration currently use , higher-volume haemofiltration may improve prognosis . The study prospective randomize multicenter trial compare two treatment patient suffer septic shock complicate acute renal failure admit ICU . One group treat early high volume haemofiltration ( 70 ml/kg/h ) second group standard volume haemofiltration ( 35 ml/kg/h ) . The main outcome one-month mortality .</brief_summary>
	<brief_title>Haemofiltration Study : IVOIRE ( hIgh VOlume Intensive Care )</brief_title>
	<detailed_description>Background Sepsis septic shock still important cause mortality intensive care medicine nowadays . Mortality range 40 80 % depend number organ failure . Therapeutic strategy consist two major component : haemodynamic stabilization restoration adequate arterial pressure optimization peripheral perfusion delivery , infection treatment . Mortality remain high despite use new antimicrobial therapy adjuvant therapy activate protein C , low dose corticoid haemofiltration . Initial observation patient acute renal failure treat haemofiltration show azotemia control , restoration sodium-water balance , elimination inflammatory mediator improvement cardiac pulmonary function demonstrate independently negative water balance . There human randomize study far demonstrate preliminary finding . Nevertheless , several author demonstrate inflammatory mediator elimination use haemofiltration . Moreover , clinical improvement seem relate ultra filtration dose early initiation therapy . Joannes-Boyau et al carry pilot study abdominal surgery patient demonstrate use high volume haemofiltration patient septic shock multiple organ failure restore hemodynamic stability drastic reduction catecholamine requirement substantial reduction observe vs. expect mortality . Objectives The principal objective study evaluate effect early Continuous High Volume Haemofiltration 28-day mortality patient septic shock complicate acute renal failure . The secondary objective assess effect High Volume Haemofiltration haemodynamics , dos catecholamine , organ failure , duration mechanical ventilation , duration renal replacement therapy need , morbidity , length ICU hospital stay , 60- 90-day mortality . Study design Open label randomize multicenter control trial two parallel group patient septic shock acute renal failure admit ICU , treat early either high volume ( 70 ml/kg/h ) standard volume ( 35 ml/kg/h ) haemofiltration . Eligibility criterion Inclusion criterion . Septic shock ( Bone criterion ) less 24 hour , RIFLE criterion : injury worse , age 18 year , write informed consent next kin . Non inclusion criterion . Cirrhosis , age 80 year , life expectancy le 3 month metastatic cancer . Intervention High volume ( 70 ml/kg/h ) vs. standard volume ( 35 ml/kg/h ) haemofiltration 96 hour . Further renal replacement therapy ( haemofiltration , standard volume allow ) may use accord investigator decision . Primary endpoint All cause 28-day mortality . Statistical aspect 460 patient plan include ( 230 group ) . A 15 % absolute reduction 28-days all-cause mortality high volume group compare standard group expect . However , reduction might great , interim analysis plan half total sample size include . Data analyze intention-to-treat basis . Duration study : 3 year .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<criteria>septic shock ( Bone criterion ) less 24 hour RIFLE criterion : injury bad age 18 year write informed consent next kin . cirrhosis age 80 year life expectancy le 3 month metastatic cancer woman : pregnancy breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Shock , Septic</keyword>
	<keyword>Renal Failure , Acute</keyword>
	<keyword>Venovenous Hemofiltration</keyword>
	<keyword>Randomized Controlled Trial</keyword>
	<keyword>Multicenter Study</keyword>
	<keyword>Mortality</keyword>
</DOC>